Halozyme Therapeutics, Inc.
HALO
$107.39
-$0.92-0.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 231.00M | 318.62M | 142.82M | 701.96M | 548.18M |
| Total Receivables | 455.83M | 457.99M | 441.27M | 346.04M | 316.34M |
| Inventory | 137.14M | 155.47M | 176.48M | 185.80M | 181.51M |
| Prepaid Expenses | 108.26M | 70.56M | 64.64M | 94.96M | 76.65M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 800.00K | 400.00K | -- | -- | -- |
| Total Current Assets | 933.02M | 1.00B | 825.21M | 1.33B | 1.12B |
|
|
|||||
| Total Current Assets | 933.02M | 1.00B | 825.21M | 1.33B | 1.12B |
| Net Property, Plant & Equipment | 84.27M | 82.23M | 82.14M | 71.42M | 71.52M |
| Long-term Investments | 581.73M | 582.32M | 580.36M | 416.82M | 416.82M |
| Goodwill | 581.73M | 582.32M | 580.36M | 416.82M | 416.82M |
| Total Other Intangibles | 922.44M | 951.96M | 981.47M | 348.54M | 366.31M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 55.94M | 53.18M | 56.15M | 55.70M | 76.58M |
| Total Assets | 2.58B | 2.67B | 2.53B | 2.22B | 2.05B |
|
|
|||||
| Total Accounts Payable | 23.61M | 14.10M | 20.90M | 15.36M | 18.69M |
| Total Accrued Expenses | 111.86M | 140.37M | 144.92M | 111.18M | 115.59M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 208.97M | 208.74M | 11.28M | 710.69M | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 344.44M | 363.21M | 177.09M | 837.23M | 134.28M |
|
|
|||||
| Total Current Liabilities | 344.44M | 363.21M | 177.09M | 837.23M | 134.28M |
| Long-Term Debt | 1.94B | 1.94B | 2.14B | 800.07M | 1.51B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 31.88M | 32.42M | 23.29M | 28.10M | 28.97M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 119.86M | 121.56M | 133.50M | 51.92M | 48.80M |
| Total Liabilities | 2.43B | 2.45B | 2.48B | 1.72B | 1.72B |
|
|
|||||
| Common Stock & APIC | 114.00K | 27.50M | 12.12M | 24.03M | 118.00K |
| Retained Earnings | 151.26M | 204.84M | 54.79M | 502.15M | 361.03M |
| Treasury Stock & Other | -7.83M | -12.70M | -18.09M | -22.26M | -28.40M |
| Total Common Equity | 143.54M | 219.64M | 48.81M | 503.92M | 332.75M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 143.54M | 219.64M | 48.81M | 503.92M | 332.75M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 143.54M | 219.64M | 48.81M | 503.92M | 332.75M |
|
|
|||||